Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

JMJD3 and UTX as key targets for gene-modified mesenchymal stem cell therapy in cartilage tissue engineering.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Exploring adenosine analogs for chondrosarcoma therapy: <i>In vitro</i> and <i>in vivo</i> insights.

Molecular therapy. Nucleic acids·2025
Same author

Double-Click Strategy Combining CuAAC and (Thia-) Diels-Alder Reactions; Application Toward Peptide Labeling.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Perioperative immunotherapy in lung cancer: Time to push the frontiers?

Med (New York, N.Y.)·2025
Same author

Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.

The New England journal of medicine·2025

Related Experiment Video

Updated: May 21, 2026

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Type II TGFβ receptor modulates chondrocyte phenotype.

Catherine Baugé1, Elise Duval, David Ollitrault

  • 1EA4652 Microenvironnement Cellulaire et Pathologies (MILPAT), Université de Caen Basse-Normandie, 14032, Caen cedex, France. catherine.bauge@unicaen.fr

Age (Dordrecht, Netherlands)
|June 2, 2012
PubMed
Summary

Aging alters chondrocyte phenotype and osteoarthritis risk by affecting transforming growth factor β (TGFβ) signaling. This study reveals TβRII expression is crucial for maintaining chondrocyte function and cartilage health.

More Related Videos

Isolation of Chondrocytes and Chondroprogenitors Using Fibronectin Adhesion and Migratory Assay
08:09

Isolation of Chondrocytes and Chondroprogenitors Using Fibronectin Adhesion and Migratory Assay

Published on: October 4, 2024

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-&#946; Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Related Experiment Videos

Last Updated: May 21, 2026

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Isolation of Chondrocytes and Chondroprogenitors Using Fibronectin Adhesion and Migratory Assay
08:09

Isolation of Chondrocytes and Chondroprogenitors Using Fibronectin Adhesion and Migratory Assay

Published on: October 4, 2024

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-&#946; Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Area of Science:

  • Biochemistry
  • Cell Biology
  • Orthopedics

Background:

  • Aging is a primary risk factor for osteoarthritis, characterized by chondrocyte phenotype changes.
  • Transforming growth factor β (TGFβ) signaling alterations may drive these chondrocyte modifications.

Purpose of the Study:

  • To investigate the role of TGFβ response in chondrocyte dedifferentiation and redifferentiation.
  • To explore the regulatory mechanisms underlying these processes.

Main Methods:

  • Chondrocyte dedifferentiation induced by serial passaging; redifferentiation via 3D alginate culture.
  • Analysis of protein and mRNA levels (Western blot, RT-PCR).
  • Investigated regulatory mechanisms using inhibitors, mRNA silencing, decoy oligonucleotides, and expression vectors.

Main Results:

  • Chondrocyte dedifferentiation reduced TGFβ receptor type II (TβRII) expression and TGFβ response.
  • Restoring TβRII expression enhanced matrix gene expression (e.g., aggrecan, type II collagen).
  • Sp1 transcription factor links TβRII expression to TGFβ response and chondrogenesis.

Conclusions:

  • TβRII expression is vital for maintaining chondrocyte phenotype, especially in aging.
  • Findings offer new insights into chondrogenesis and potential therapeutic targets for osteoarthritis.